Target intelligence / Profile preview

Omega-6 polyunsaturated fatty acid metabolic pathway

Molecular classification
Other (Metabolic pathway, not a single molecule or protein)
01

Overview

The **omega‑6 polyunsaturated fatty acid (PUFA) metabolic pathway** refers to the series of enzymatic reactions that convert dietary omega‑6 essential fatty acids—primarily linoleic acid—into longer-chain metabolites such as arachidonic acid. These metabolites are further processed into bioactive lipid mediators called eicosanoids, which play key roles in regulating inflammation, platelet aggregation, vasoconstriction, and other physiological processes[1][2][3]. The enzymes involved include desaturases and elongases shared with the omega‑3 PUFA pathways; thus, both families compete for these enzymes. The balance between omega‑6–derived pro-inflammatory mediators (such as those from arachidonic acid) and omega‑3–derived anti-inflammatory mediators is critical for health. Overconsumption of omega‑6 PUFAs relative to omega‑3s is associated with increased risk for inflammatory diseases, cardiovascular disease, cancer progression, and other chronic conditions due to excessive production of pro-inflammatory eicosanoids[2][3][5]. This "target" is not a single molecular entity but rather a complex biochemical network; therefore it does not fit the definition of a druggable target like an enzyme or receptor. **Note:** This entry describes a *metabolic pathway*, not an individual molecule or canonical therapeutic target such as an enzyme or receptor. It cannot be directly targeted by drugs in the same way as proteins can be; instead interventions typically focus on modulating dietary intake or inhibiting specific enzymes within this pathway. If you require information about specific molecular targets within this pathway—such as cyclooxygenase (COX), lipoxygenase (LOX), delta-desaturases—or about particular metabolites like arachidonic acid or its receptors/effectors, please specify so more structured data can be provided.

Other names
Omega-6 PUFA metabolic pathwayn-6 polyunsaturated fatty acid metabolismLinoleic acid/arachidonic acid pathway (context-dependent)Omega-6 fatty acid biosynthesis and signaling
02

Biological functions

Fatty acid metabolismRegulation of inflammationCell membrane composition and fluidityModulation of gene expression via transcription factors (e.g., PPARs, NFκB, SREBP1)
03

Disease associations

Cardiovascular diseaseInflammationCancer

Beyond the preview

Go deeper on Omega-6 polyunsaturated fatty acid metabolic pathway.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Omega-6 polyunsaturated fatty acid metabolic pathway.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call